{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:28:14Z","timestamp":1793982494338,"version":"4.8.0"},"reference-count":94,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2021.0296","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T08:47:26Z","timestamp":1633596446000},"source":"Crossref","is-referenced-by-count":72,"title":["Scabies: epidemiology, diagnosis, and treatment"],"prefix":"10.3238","author":[{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wohlrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"10.3238\/arztebl.m2021.0296_ref1","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C, Aebischer A, Neufeld M, et al.: Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges 2019; 17: 15\u201323","DOI":"10.1111\/ddg.13706"},{"key":"10.3238\/arztebl.m2021.0296_ref2","doi-asserted-by":"crossref","unstructured":"Nenoff P, Suss A, Schulze I, et al.: Skabies-Renaissance einer Ektoparasitose: Diagnostik und Therapie \u2013 Vorgehen in der Praxis. Hautarzt 2021; 72: 125\u201336","DOI":"10.1007\/s00105-020-04729-6"},{"key":"10.3238\/arztebl.m2021.0296_ref3","doi-asserted-by":"crossref","unstructured":"Boralevi F, Diallo A, Miquel J, et al.: Clinical phenotype of scabies by age. Pediatrics 2014; 133: e910\u20136","DOI":"10.1542\/peds.2013-2880"},{"key":"10.3238\/arztebl.m2021.0296_ref4","doi-asserted-by":"crossref","unstructured":"Elsner E, Uhlmann T, Krause S, Hartmann R: Anstieg von Skabies und Therapierefrakt\u00e4rit\u00e4t bei Bundeswehrangeh\u00f6rigen: Acht-Jahre-Follow-up-Studie aus der Hautklinik des Bundeswehrkrankenhauses Berlin (2012\u20132019). Hautarzt 2020; 71: 447\u201354","DOI":"10.1007\/s00105-020-04608-0"},{"key":"10.3238\/arztebl.m2021.0296_ref5","doi-asserted-by":"crossref","unstructured":"Kortas AZ, Polenz J, von Hayek J, et al.: Screening for infectious diseases among asylum seekers newly arrived in Germany in 2015: a systematic single-centre analysis. Public Health 2017; 153: 1\u20138","DOI":"10.1016\/j.puhe.2017.07.011"},{"key":"10.3238\/arztebl.m2021.0296_ref6","doi-asserted-by":"crossref","unstructured":"Karimkhani C, Colombara DV, Drucker AM, et al.: The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis 2017; 17: 1247\u201354","DOI":"10.1016\/S1473-3099(17)30483-8"},{"key":"10.3238\/arztebl.m2021.0296_ref7","doi-asserted-by":"crossref","unstructured":"Arora P, Rudnicka L, Sar-Pomian M, et al.: Scabies: a comprehensive review and current perspectives. Dermatol Ther 2020; 33: e13746","DOI":"10.1111\/dth.13746"},{"key":"10.3238\/arztebl.m2021.0296_ref8","doi-asserted-by":"crossref","unstructured":"Leung AKC, Lam JM, Leong KF: Scabies: a neglected global disease. Curr Pediatr Rev 2020; 16: 33\u201342","DOI":"10.2174\/1573396315666190717114131"},{"key":"10.3238\/arztebl.m2021.0296_ref9","doi-asserted-by":"crossref","unstructured":"Mellanby K: The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 1944; 35: 197\u2013206","DOI":"10.1017\/S0031182000021612"},{"key":"10.3238\/arztebl.m2021.0296_ref10","doi-asserted-by":"crossref","unstructured":"Arlian LG, Vyszenski-Moher DL: Life cycle of sarcoptes scabiei var. canis. J Parasitol 1988; 74: 427\u201330","DOI":"10.2307\/3282050"},{"key":"10.3238\/arztebl.m2021.0296_ref11","doi-asserted-by":"crossref","unstructured":"Hamm H: Skabies. In: Von Stebut E (ed.): Reisedermatosen: Berlin, Heidelberg, New York: Springer 2015; 151\u20137","DOI":"10.1007\/978-3-662-44705-5_33"},{"key":"10.3238\/arztebl.m2021.0296_ref12","doi-asserted-by":"crossref","unstructured":"Mellanby K: Transmission of scabies. Br Med J 1941; 2: 405\u20136","DOI":"10.1136\/bmj.2.4211.405"},{"key":"10.3238\/arztebl.m2021.0296_ref13","doi-asserted-by":"crossref","unstructured":"Arlian LG, Runyan RA, Achar S, Estes SA: Survival and infectivity of sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 1984; 11 (2 Pt 1): 210\u20135","DOI":"10.1016\/S0190-9622(84)70151-4"},{"key":"10.3238\/arztebl.m2021.0296_ref14","doi-asserted-by":"crossref","unstructured":"Arlian LG, Runyan RA, Sorlie LB, Estes SA: Host-seeking behavior of sarcoptes scabiei. J Am Acad Dermatol 1984; 11 (4 Pt 1): 594\u20138","DOI":"10.1016\/S0190-9622(84)70212-X"},{"key":"10.3238\/arztebl.m2021.0296_ref15","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C, Feldmeier H, F\u00f6lster-Holst R, et al.: S1 guidelines on the diagnosis and treatment of scabies\u2014short version. J Dtsch Dermatol Ges 2016; 14: 1155\u201367","DOI":"10.1111\/ddg.13130"},{"key":"10.3238\/arztebl.m2021.0296_ref16","doi-asserted-by":"crossref","unstructured":"Thomas C, Coates SJ, Engelman D, et al.: Ectoparasites: scabies. J Am Acad Dermatol 2020; 82: 533\u201348","DOI":"10.1016\/j.jaad.2019.05.109"},{"key":"10.3238\/arztebl.m2021.0296_ref17","doi-asserted-by":"crossref","unstructured":"Hamm H, Stoevesandt J, Sunderk\u00f6tter C: Skabies im Alter. Z Gerontol Geriatr 2019; 52: 795\u2013807","DOI":"10.1007\/s00391-019-01650-z"},{"key":"10.3238\/arztebl.m2021.0296_ref18","doi-asserted-by":"crossref","unstructured":"Cassell JA, Middleton J, Nalabanda A, et al.: Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 2018; 18: 894\u2013902","DOI":"10.1016\/S1473-3099(18)30347-5"},{"key":"10.3238\/arztebl.m2021.0296_ref19","doi-asserted-by":"crossref","unstructured":"Li FZ, Chen S: Diagnostic accuracy of dermoscopy for scabies. Korean J Parasitol 2020; 58: 669\u201374","DOI":"10.3347\/kjp.2020.58.6.669"},{"key":"10.3238\/arztebl.m2021.0296_ref20","doi-asserted-by":"crossref","unstructured":"Mang R, Kremer A, Lehmann P, Assmann T: Videodermoscopic clues for scabies diagnosis and assessment of therapeutic efficacy. J Dtsch Dermatol Ges 2020; 18: 1022\u20134","DOI":"10.1111\/ddg.14155"},{"key":"10.3238\/arztebl.m2021.0296_ref21","doi-asserted-by":"crossref","unstructured":"Engelman D, Yoshizumi J, Hay RJ, et al.: The 2020 International Alliance for the Control of Scabies consensus criteria for the diagnosis of Scabies. Br J Dermatol 2020; 183: 808\u201320","DOI":"10.1111\/bjd.18943"},{"key":"10.3238\/arztebl.m2021.0296_ref22","doi-asserted-by":"crossref","unstructured":"Hamm H, Beiteke U, H\u00f6ger PH, Seitz CS, Thaci D, Sunderk\u00f6tter C: Treatment of scabies with 5% permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges 2006; 4: 407\u201313","DOI":"10.1111\/j.1610-0387.2006.05941.x"},{"key":"10.3238\/arztebl.m2021.0296_ref23","doi-asserted-by":"crossref","unstructured":"Hu S, Bigby M: Treating scabies: results from an updated Cochrane review. Arch Dermatol 2008; 144: 1638\u201340","DOI":"10.1001\/archdermatol.2008.513"},{"key":"10.3238\/arztebl.m2021.0296_ref24","doi-asserted-by":"crossref","unstructured":"Rosumeck S, Nast A, Dressler C: Evaluation of ivermectin vs permethrin for treating scabies\u2014summary of a Cochrane review. JAMA Dermatol 2019; 155: 730\u20132","DOI":"10.1001\/jamadermatol.2019.0279"},{"key":"10.3238\/arztebl.m2021.0296_ref25","doi-asserted-by":"crossref","unstructured":"Dhana A, Yen H, Okhovat JP, et al.: Ivermectin versus permethrin in the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 2018; 78: 194\u20138","DOI":"10.1016\/j.jaad.2017.09.006"},{"key":"10.3238\/arztebl.m2021.0296_ref26","doi-asserted-by":"crossref","unstructured":"Wohlrab J, Staubach P, Augustin M, et al.: S2k-Leitlinie zum Gebrauch von Pr\u00e4parationen zur lokalen Anwendung auf der Haut (Topika). J Dtsch Dermatol Ges 2018; 16: 376\u201392","DOI":"10.1111\/ddg.13473_g"},{"key":"10.3238\/arztebl.m2021.0296_ref27","doi-asserted-by":"crossref","unstructured":"Salavastru CM, Chosidow O, Boffa MJ, et al.: European guideline for the management of scabies. J Eur Acad Dermatol Venereol 2017; 31: 1248\u201353","DOI":"10.1111\/jdv.14351"},{"key":"10.3238\/arztebl.m2021.0296_ref28","doi-asserted-by":"crossref","unstructured":"Nemecek R, Stockbauer A, Lexa M, et al.: Application errors associated with topical treatment of scabies: an observational study. J Dtsch Dermatol Ges 2020; 18: 554\u20139","DOI":"10.1111\/ddg.14122"},{"key":"10.3238\/arztebl.m2021.0296_ref29","doi-asserted-by":"crossref","unstructured":"Jittamala P, Monteiro W, Smit MR, et al.: A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLoS Negl Trop Dis 2021; 15: e0009144","DOI":"10.1371\/journal.pntd.0009144"},{"key":"10.3238\/arztebl.m2021.0296_ref30","doi-asserted-by":"crossref","unstructured":"Levy M, Martin L, Bursztejn AC, et al.: Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol 2020; 182: 1003\u20136","DOI":"10.1111\/bjd.18369"},{"key":"10.3238\/arztebl.m2021.0296_ref31","doi-asserted-by":"crossref","unstructured":"Wohlrab J, Stadie L, Neubert RHH, Bosse K: Entwicklung eines Ivermectin-haltigen Saftes als Magistralrezeptur f\u00fcr Kinder zur Therapie der Skabies. Hautarzt 2021; 72: 720\u20138","DOI":"10.1007\/s00105-021-04806-4"},{"key":"10.3238\/arztebl.m2021.0296_ref32","doi-asserted-by":"crossref","unstructured":"Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS: Prospects for moxidectin as a new oral treatment for human scabies. PLoS Negl Trop Dis 2016; 10: e0004389","DOI":"10.1371\/journal.pntd.0004389"},{"key":"10.3238\/arztebl.m2021.0296_ref33","unstructured":"Robert Koch-Institut: Skabies (Kr\u00e4tze). RKI-Ratgeber. www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Skabies. html (last accessed on 26 March 2021)."},{"key":"10.3238\/arztebl.m2021.0296_ref34","doi-asserted-by":"crossref","unstructured":"Leeyaphan C, Pluetrattanabha N, Limphoka P, Bunyaratavej S: Scabicidal effect of heat on the in vitro survival of scabies mites and their eggs: optimal temperature and exposure time. Indian J Dermatol Venereol Leprol 2019; 85: 647\u20139","DOI":"10.4103\/ijdvl.IJDVL_198_19"},{"key":"10.3238\/arztebl.m2021.0296_ref35","doi-asserted-by":"crossref","unstructured":"Bernigaud C, Fernando DD, Lu H, et al.: How to eliminate scabies parasites from fomites: a high-throughput ex vivo experimental study. J Am Acad Dermatol 2020; 83: 241\u20135","DOI":"10.1016\/j.jaad.2019.11.069"},{"key":"10.3238\/arztebl.m2021.0296_ref36","doi-asserted-by":"crossref","unstructured":"Mounsey KE, Murray HC, King M, Oprescu F: Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward. Epidemiol Infect 2016; 144: 2462\u201371","DOI":"10.1017\/S0950268816000443"},{"key":"10.3238\/arztebl.m2021.0296_ref37","doi-asserted-by":"crossref","unstructured":"Stoevesandt J, Carl\u00e9 L, Leverkus M, Hamm H: Control of large institutional scabies outbreaks. J Dtsch Dermatol Ges 2012; 10: 637\u201347","DOI":"10.1111\/j.1610-0387.2012.07892.x"},{"key":"10.3238\/arztebl.m2021.0296_ref38","doi-asserted-by":"crossref","unstructured":"Mang R, Kremer A, Lehmann P, Assmann T: Skabies \u2013 klinische Therapieresistenz auf Permethrin: Fallbeschreibungen und eine kritische Auseinandersetzung mit den aktuellen Therapieempfehlungen. Hautarzt 2021; 72: 595\u20139","DOI":"10.1007\/s00105-021-04783-8"},{"key":"10.3238\/arztebl.m2021.0296_ref39","doi-asserted-by":"crossref","unstructured":"Hackenberg B, Horvath ON, Petachti M, et al.: Skabiestherapie in Deutschland: Ergebnisse einer bundesweiten Umfrage mit besonderem Fokus auf die Wirksamkeit der Erstlinientherapie mit Permethrin. Hautarzt 2020; 71: 374\u20139","DOI":"10.1007\/s00105-020-04561-y"},{"key":"10.3238\/arztebl.m2021.0296_ref40","doi-asserted-by":"crossref","unstructured":"Aussy A, Houivet E, Hebert V, et al.: Risk factors for treatment failure in scabies: a cohort study. Br J Dermatol 2019; 180: 888\u201393","DOI":"10.1111\/bjd.17348"},{"key":"10.3238\/arztebl.m2021.0296_ref41","doi-asserted-by":"crossref","unstructured":"Kerwat K, Just M, Wulf H: Das deutsche Infektionsschutzgesetz (IfSG). Anasthesiol Intensivmed Notfallmed Schmerzther 2009; 44: 182\u20133","DOI":"10.1055\/s-0029-1215548"},{"key":"10.3238\/arztebl.m2021.0296_ref42","doi-asserted-by":"crossref","unstructured":"Johnston G, Sladden M: Scabies: diagnosis and treatment. BMJ 2005; 331: 619\u201322","DOI":"10.1136\/bmj.331.7517.619"},{"key":"10.3238\/arztebl.m2021.0296_ref43","doi-asserted-by":"crossref","unstructured":"Vyas P, Kinsey SE, Goldstone AH: Scabies infestation following autologous bone marrow transplantation. Leuk Lymphoma 1990; 3: 73\u20134","DOI":"10.3109\/10428199009050978"},{"key":"10.3238\/arztebl.m2021.0296_ref44","doi-asserted-by":"crossref","unstructured":"Venning VA, Millard PR: Recurrent scabies with unusual clinical features in a renal transplant recipient. Br J Dermatol 1992; 126: 204\u20135","DOI":"10.1111\/j.1365-2133.1992.tb07826.x"},{"key":"10.3238\/arztebl.m2021.0296_ref45","doi-asserted-by":"crossref","unstructured":"Minist\u00e8re de la Sant\u00e9, de la Famille et des Personnes Handicap\u00e9es, Direction G\u00e9n\u00e9rale de la Sant\u00e9, Conseil Sup\u00e9rieur d\u2018Hygi\u00e8ne Publique de France: Avis du Conseil Sup\u00e9rieur d\u2019Hygi\u00e8ne Publique de France, section des maladies transmissibles, relatif \u00e0 la conduite \u00e0 tenir devant un cas de gale (s\u00e9ance du 27 juin 2003). Ann Dermatol Venereol 2004; 131: 1119\u201321","DOI":"10.1016\/S0151-9638(04)93857-4"},{"key":"10.3238\/arztebl.m2021.0296_ref46","doi-asserted-by":"crossref","unstructured":"Hubler WR, Jr.: Epidemic Norwegian scabies. Arch Dermatol 1976; 112: 179\u201381","DOI":"10.1001\/archderm.112.2.179"},{"key":"10.3238\/arztebl.m2021.0296_ref47","doi-asserted-by":"crossref","unstructured":"Lassa S, Campbell MJ, Bennett CE: Epidemiology of scabies prevalence in the U.K. from general practice records. Br J Dermatol 2011; 164: 1329\u201334","DOI":"10.1111\/j.1365-2133.2011.10264.x"},{"key":"10.3238\/arztebl.m2021.0296_ref48","doi-asserted-by":"crossref","unstructured":"Cox NH, Paterson WD: Epidemiology of scabies: the new epidemic. Lancet 1991; 337: 1547\u20138","DOI":"10.1016\/0140-6736(91)93239-6"},{"key":"10.3238\/arztebl.m2021.0296_ref49","doi-asserted-by":"crossref","unstructured":"Heukelbach J, Feldmeier H: Scabies. Lancet 2006; 367: 1767\u201374","DOI":"10.1016\/S0140-6736(06)68772-2"},{"key":"10.3238\/arztebl.m2021.0296_ref50","doi-asserted-by":"crossref","unstructured":"Vorou R, Remoudaki HD, Maltezou HC: Nosocomial scabies. J Hosp Infect 2007; 65: 9\u201314","DOI":"10.1016\/j.jhin.2006.08.012"},{"key":"10.3238\/arztebl.m2021.0296_ref51","doi-asserted-by":"crossref","unstructured":"Collinson S, Ward R: A nurse-led response to unmet needs of homeless migrants in inner London. Br J Nurs 2010; 19: 36\u201341","DOI":"10.12968\/bjon.2010.19.1.45910"},{"key":"10.3238\/arztebl.m2021.0296_ref52","doi-asserted-by":"crossref","unstructured":"He R, Gu X, Lai W, et al.: Transcriptome-microRNA analysis of Sarcoptes scabiei and host immune response. PLoS One 2017; 12: e0177733","DOI":"10.1371\/journal.pone.0177733"},{"key":"10.3238\/arztebl.m2021.0296_ref53","doi-asserted-by":"crossref","unstructured":"Jannic A, Bernigaud C, Brenaut E, Chosidow O: Scabies itch. Dermatol Clin 2018; 36: 301\u20138","DOI":"10.1016\/j.det.2018.02.009"},{"key":"10.3238\/arztebl.m2021.0296_ref54","doi-asserted-by":"crossref","unstructured":"Aung PTZ, Cuningham W, Hwang K, et al.: Scabies and risk of skin sores in remote Australian Aboriginal communities: a self-controlled case series study. PLoS Negl Trop Dis 2018; 12: e0006668","DOI":"10.1371\/journal.pntd.0006668"},{"key":"10.3238\/arztebl.m2021.0296_ref55","doi-asserted-by":"crossref","unstructured":"Liu JM, Wang HW, Chang FW, et al.: The effects of climate factors on scabies. A 14-year population-based study in Taiwan. Parasite 2016; 23: 54","DOI":"10.1051\/parasite\/2016065"},{"key":"10.3238\/arztebl.m2021.0296_ref56","doi-asserted-by":"crossref","unstructured":"Lavery MJ, Stull C, Nattkemper LA, et al.: Nocturnal pruritus: prevalence, characteristics, and impact on ItchyQoL in a chronic itch population. Acta Derm Venereol 2017; 97: 513\u20135","DOI":"10.2340\/00015555-2560"},{"key":"10.3238\/arztebl.m2021.0296_ref57","doi-asserted-by":"crossref","unstructured":"Lopez-Sundh AE, Gomez-Fernandez C, Marlasca-SanMartin P, et al.: Neonatal scabies in times of confinement: An unexpected guest to be recognised. J Paediatr Child Health 2020; doi: 10.1111\/jpc.15238. Online ahead of print","DOI":"10.1111\/jpc.15238"},{"key":"10.3238\/arztebl.m2021.0296_ref58","doi-asserted-by":"crossref","unstructured":"Tesner B, Williams NO, Brodell RT: The pathophysiologic basis of scabietic nodules. J Am Acad Dermatol 2007; 57 (2 Suppl): S56\u20137","DOI":"10.1016\/j.jaad.2007.04.006"},{"key":"10.3238\/arztebl.m2021.0296_ref59","doi-asserted-by":"crossref","unstructured":"Ruby KN, Loo EY, Mann JA, LeBlanc RE: Post-scabietic nodules: mimicker of infantile indeterminate cell histiocytosis and potential diagnostic pitfall. J Cutan Pathol 2020; 47: 52\u20136","DOI":"10.1111\/cup.13557"},{"key":"10.3238\/arztebl.m2021.0296_ref60","doi-asserted-by":"crossref","unstructured":"Kokubu H, Takahashi T, Tateishi C, et al.: Serological investigation of bullous scabies and review of the published work. J Dermatol 2019; 46: e324\u2013e5","DOI":"10.1111\/1346-8138.14883"},{"key":"10.3238\/arztebl.m2021.0296_ref61","doi-asserted-by":"crossref","unstructured":"Swe PM, Christian LD, Lu HC, et al.: Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes\u2014an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis 2017; 11: e0005437","DOI":"10.1371\/journal.pntd.0005437"},{"key":"10.3238\/arztebl.m2021.0296_ref62","doi-asserted-by":"crossref","unstructured":"Yosipovitch G, Misery L, Proksch E, et al.: Skin barrier damage and itch: review of mechanisms, topical management and future directions. Acta Derm Venereol 2019; 99: 1201\u20139","DOI":"10.2340\/00015555-3296"},{"key":"10.3238\/arztebl.m2021.0296_ref63","doi-asserted-by":"crossref","unstructured":"Ueda T, Katsura Y, Sasaki A, et al.: Gray-edged line sign of scabies burrow. J Dermatol 2021; 48: 190\u20138","DOI":"10.1111\/1346-8138.15650"},{"key":"10.3238\/arztebl.m2021.0296_ref64","doi-asserted-by":"crossref","unstructured":"Schuh S, Weins AB, Welzel J: Nichtinvasive bildgebende Diagnostik bei Hauterkrankungen im Kindesalter. Hautarzt 2021; 72: 199\u2013206","DOI":"10.1007\/s00105-020-04753-6"},{"key":"10.3238\/arztebl.m2021.0296_ref65","doi-asserted-by":"crossref","unstructured":"Walton SF: The immunology of susceptibility and resistance to scabies. Parasite Immunol 2010; 32: 532\u201340","DOI":"10.1111\/j.1365-3024.2010.01218.x"},{"key":"10.3238\/arztebl.m2021.0296_ref66","doi-asserted-by":"crossref","unstructured":"Mika A, Reynolds SL, Mohlin FC, et al.: Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS One 2012; 7: e40489","DOI":"10.1371\/journal.pone.0040489"},{"key":"10.3238\/arztebl.m2021.0296_ref67","doi-asserted-by":"crossref","unstructured":"Bergstrom FC, Reynolds S, Johnstone M, et al.: Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol 2009; 182: 7809\u201317","DOI":"10.4049\/jimmunol.0804205"},{"key":"10.3238\/arztebl.m2021.0296_ref68","doi-asserted-by":"crossref","unstructured":"Han L, Dong X: Itch mechanisms and circuits. Annu Rev Biophys 2014; 43: 331\u201355","DOI":"10.1146\/annurev-biophys-051013-022826"},{"key":"10.3238\/arztebl.m2021.0296_ref69","doi-asserted-by":"crossref","unstructured":"Tornero-Velez R, Davis J, Scollon EJ, et al.: A pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application. Toxicol Sci 2012; 130: 33\u201347","DOI":"10.1093\/toxsci\/kfs236"},{"key":"10.3238\/arztebl.m2021.0296_ref70","unstructured":"Nanda J, Juergens AL: Permethrin. 2020 May 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan\u2013. PMID: 31985943."},{"key":"10.3238\/arztebl.m2021.0296_ref71","doi-asserted-by":"crossref","unstructured":"Pallesen K, Lassen JA, Munk NT, et al.: In vitro survival of scabies mites. Clin Exp Dermatol 2020; 45: 712\u20135","DOI":"10.1111\/ced.14209"},{"key":"10.3238\/arztebl.m2021.0296_ref72","doi-asserted-by":"crossref","unstructured":"Chhaiya SB, Patel VJ, Dave JN, et al.: Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol 2012; 78: 605\u201310","DOI":"10.4103\/0378-6323.100571"},{"key":"10.3238\/arztebl.m2021.0296_ref73","doi-asserted-by":"crossref","unstructured":"Dourmishev AL, Dourmishev LA, Schwartz RA: Ivermectin: pharmacology and application in dermatology. Int J Dermatol 2005; 44: 981\u20138","DOI":"10.1111\/j.1365-4632.2004.02253.x"},{"key":"10.3238\/arztebl.m2021.0296_ref74","doi-asserted-by":"crossref","unstructured":"Chosidow A, Gendrel D: Tol\u00e9rance de l\u2019ivermectine orale chez l\u2019enfant. Arch Pediatr 2016; 23: 204\u20139","DOI":"10.1016\/j.arcped.2015.11.002"},{"key":"10.3238\/arztebl.m2021.0296_ref75","doi-asserted-by":"crossref","unstructured":"St\u00e4nder S, Kirschstein DJ, Kohl-Sobania M, et al.: Effectiveness and adverse events of ivermectin treatment for scabies in 30 infant patients: report from a German single centre. J Eur Acad Dermatol Venereol 2020; 34: e736\u20137","DOI":"10.1111\/jdv.16554"},{"key":"10.3238\/arztebl.m2021.0296_ref76","doi-asserted-by":"crossref","unstructured":"Laing R, Gillan V, Devaney E: Ivermectin\u2014old drug, new tricks? Trends Parasitol 2017; 33: 463\u201372","DOI":"10.1016\/j.pt.2017.02.004"},{"key":"10.3238\/arztebl.m2021.0296_ref77","doi-asserted-by":"crossref","unstructured":"King CL: Is ivermectin safe in pregnancy? Lancet Glob Health 2020; 8: e12\u20133","DOI":"10.1016\/S2214-109X(19)30490-5"},{"key":"10.3238\/arztebl.m2021.0296_ref78","doi-asserted-by":"crossref","unstructured":"Van Hees S, Raimon S, Fodjo JNS, Colebunders R: Safety of ivermectin during pregnancy. Lancet Glob Health 2020; 8: e338","DOI":"10.1016\/S2214-109X(19)30555-8"},{"key":"10.3238\/arztebl.m2021.0296_ref79","doi-asserted-by":"crossref","unstructured":"Schraven AL, Stannard HJ, Old JM: A systematic review of moxidectin as a treatment for parasitic infections in mammalian species. Parasitol Res 2021; 120: 1167\u201381","DOI":"10.1007\/s00436-021-07092-0"},{"key":"10.3238\/arztebl.m2021.0296_ref80","doi-asserted-by":"crossref","unstructured":"Milton P, Hamley JID, Walker M, Basanez MG: Moxidectin: an oral treatment for human onchocerciasis. Expert Rev Anti Infect Ther 2020; 18: 1067\u201381","DOI":"10.1080\/14787210.2020.1792772"},{"key":"10.3238\/arztebl.m2021.0296_ref81","doi-asserted-by":"crossref","unstructured":"Cotreau MM, Warren S, Ryan JL, et al.: The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans. J Clin Pharmacol 2003; 43: 1108\u201315","DOI":"10.1177\/0091270003257456"},{"key":"10.3238\/arztebl.m2021.0296_ref82","doi-asserted-by":"crossref","unstructured":"Liu X, Walton S, Mounsey K: Vaccine against scabies: necessity and possibility. Parasitology 2014; 141: 725\u201332","DOI":"10.1017\/S0031182013002047"},{"key":"10.3238\/arztebl.m2021.0296_ref83","doi-asserted-by":"crossref","unstructured":"Buehlmann M, Beltraminelli H, Strub C, et al.: Scabies outbreak in an intensive care unit with 1,659 exposed individuals\u2014key factors for controlling the outbreak. Infect Control Hosp Epidemiol 2009; 30: 354\u201360","DOI":"10.1086\/596113"},{"key":"10.3238\/arztebl.m2021.0296_ref84","doi-asserted-by":"crossref","unstructured":"Capobussi M, Sabatino G, Donadini A, et al.: Control of scabies outbreaks in an Italian hospital: an information-centered management strategy. Am J Infect Control 2014; 42: 316\u201320","DOI":"10.1016\/j.ajic.2013.10.006"},{"key":"10.3238\/arztebl.m2021.0296_ref85","doi-asserted-by":"crossref","unstructured":"White LC, Lanza S, Middleton J, et al.: The management of scabies outbreaks in residential care facilities for the elderly in England: a review of current health protection guidelines. Epidemiol Infect 2016; 144: 3121\u201330","DOI":"10.1017\/S0950268816001746"},{"key":"10.3238\/arztebl.m2021.0296_ref86","doi-asserted-by":"crossref","unstructured":"Meyersburg D, Kaiser A, Bauer JW: Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study. J Dermatolog Treat 2020; 1\u20134. doi: 10.1080\/09546634.2020.1774489. Online ahead of print","DOI":"10.1080\/09546634.2020.1774489"},{"key":"10.3238\/arztebl.m2021.0296_ref87","doi-asserted-by":"crossref","unstructured":"Pasay C, Arlian L, Morgan M, et al.: High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol 2008; 22: 82\u20138","DOI":"10.1111\/j.1365-2915.2008.00716.x"},{"key":"10.3238\/arztebl.m2021.0296_ref88","doi-asserted-by":"crossref","unstructured":"Andriantsoanirina V, Izri A, Botterel F, et al.: Molecular survey of knockdown resistance to pyrethroids in human scabies mites. Clin Microbiol Infect 2014; 20: O139\u201341","DOI":"10.1111\/1469-0691.12334"},{"key":"10.3238\/arztebl.m2021.0296_ref89","doi-asserted-by":"crossref","unstructured":"Mounsey KE, Pasay CJ, Arlian LG, et al.: Increased transcription of glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors 2010; 3: 43","DOI":"10.1186\/1756-3305-3-43"},{"key":"10.3238\/arztebl.m2021.0296_ref90","doi-asserted-by":"crossref","unstructured":"Atif M, Smith JJ, Estrada-Mondragon A, et al.: GluClR-mediated inhibitory postsynaptic currents reveal targets for ivermectin and potential mechanisms of ivermectin resistance. PLoS Pathog 2019; 15: e1007570","DOI":"10.1371\/journal.ppat.1007570"},{"key":"10.3238\/arztebl.m2021.0296_ref91","doi-asserted-by":"crossref","unstructured":"De Sainte Marie B, Mallet S, Gaudy-Marqueste C, et al.: Gales en \u00e9chec de traitement: \u00e9tude observationnelle. Ann Dermatol Venereol 2016; 143: 9\u201315 CrossRef","DOI":"10.1016\/j.annder.2015.10.588"},{"key":"10.3238\/arztebl.m2021.0296_ref92","doi-asserted-by":"crossref","unstructured":"Arlian LG, Morgan MS, Paul CC: Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J Med Entomol 2006; 43: 283\u20137","DOI":"10.1603\/0022-2585(2006)043[0283:ETSMAS]2.0.CO;2"},{"key":"10.3238\/arztebl.m2021.0296_ref93","doi-asserted-by":"crossref","unstructured":"Van Neste D: Immuno-allergological aspects of scabies. A comparative study of spontaneous blastogenesis in the dermal infiltrates of common and hyperkeratotic scabies, allergic contact dermatitis and irritant dermatitis. Arch Dermatol Res 1982; 274: 159\u201367","DOI":"10.1007\/BF00510369"},{"key":"10.3238\/arztebl.m2021.0296_ref94","unstructured":"Musalek M, Kutzer E: Psychiatrische und parasitologische Aspekte des Dermatozooenwahns. Wien Klin Wochenschr 1989; 101: 153\u201360."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:13:29Z","timestamp":1638767609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2021.0296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":94,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2021.0296","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}